News

FDA approves first treatment for advanced epithelioid sarcoma
- Author:
- Laura Nikolaides
Publish date: January 24, 2020
News

FDA approves pembrolizumab for BCG-unresponsive NMIBC with CIS
- Author:
- Laura Nikolaides
Publish date: January 8, 2020
News

FDA approves antibody-drug conjugate for advanced urothelial cancer
- Author:
- Laura Nikolaides
Publish date: December 19, 2019
News

FDA expands Xtandi approval to mCSPC
- Author:
- Laura Nikolaides
Publish date: December 17, 2019
News

FDA approves atezolizumab combo as first line for advanced NSCLC
- Author:
- Laura Nikolaides
Publish date: December 4, 2019
News

FDA issues warning for CDK 4/6 inhibitors
- Author:
- Laura Nikolaides
Publish date: September 13, 2019
News

FDA approves darolutamide for nonmetastatic CRPC
- Author:
- Laura Nikolaides
Publish date: July 31, 2019
News

FDA approves bevacizumab-bvzr for several cancers
- Author:
- Laura Nikolaides
Publish date: June 28, 2019
News

FDA approves pembrolizumab for advanced SCLC
- Author:
- Laura Nikolaides
Publish date: June 18, 2019
News

FDA approves trastuzumab-anns for HER2-positive breast, gastric cancer
- Author:
- Laura Nikolaides
Publish date: June 14, 2019
News
FDA approves NovoTTF-100L System for advanced mesothelioma
- Author:
- Laura Nikolaides
Publish date: May 24, 2019
News
FDA approves T-DM1 as adjuvant treatment
- Author:
- Laura Nikolaides
Publish date: May 6, 2019
News

FDA approves pembrolizumab for first-line stage III NSCLC
- Author:
- Laura Nikolaides
Publish date: April 12, 2019
News

FDA approves palbociclib for men with HR+/HER2- advanced breast cancer
- Author:
- Laura Nikolaides
Publish date: April 4, 2019
News

FDA approves cabozantinib for previously treated HCC
- Author:
- Laura Nikolaides
Publish date: January 15, 2019